Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Hong Kong · Delayed Price · Currency is HKD 0.6150
-0.0850 (-12.14%)
Oct 8, 2026, 11:18 AM HKT
HKG:1643 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 198.95 | 145.17 | 214.07 | 344.08 | 399.66 | 360.7 | |
Revenue Growth | -1.61% | -32.18% | -37.78% | -13.91% | 10.80% | 16.85% |
Cost of Revenue | 169.47 | 121.61 | 158.87 | 239.9 | 228.87 | 202.27 |
Gross Profit | 29.49 | 23.56 | 55.2 | 104.18 | 170.79 | 158.43 |
Selling, General & Admin | 67.86 | 40.1 | 31.37 | 35.81 | 41.69 | 44.79 |
Operating Expenses | 83.13 | 40.1 | 31.37 | 35.81 | 41.69 | 44.79 |
Operating Income | -53.65 | -16.54 | 23.83 | 68.37 | 129.1 | 113.64 |
Interest Expense | -0.06 | -0.01 | -0 | -0.01 | -0.01 | -0.07 |
Interest & Investment Income | 0.61 | 0.71 | 0.77 | 0.91 | 0.68 | 0.42 |
Currency Exchange Gain (Loss) | 4.02 | 1.87 | -1.26 | -1.23 | -5.91 | 0.04 |
Other Non Operating Income (Expenses) | 0.09 | 0.14 | 0.07 | 0.27 | 0.42 | 0.2 |
EBT Excluding Unusual Items | -48.94 | -13.82 | 23.41 | 68.31 | 124.26 | 114.22 |
Gain (Loss) on Sale of Assets | - | -0.2 | -8.59 | - | - | - |
Other Unusual Items | - | - | - | - | 0.06 | - |
Pretax Income | -48.94 | -14.02 | 14.82 | 68.31 | 124.32 | 114.22 |
Income Tax Expense | -7.03 | -0.46 | 5.15 | 19.51 | 36.5 | 32.45 |
Net Income | -41.91 | -13.56 | 9.67 | 48.8 | 87.83 | 81.78 |
Net Income to Common | -41.91 | -13.56 | 9.67 | 48.8 | 87.83 | 81.78 |
Net Income Growth | - | - | -80.18% | -44.44% | 7.40% | 28.63% |
Shares Outstanding (Basic) | 720 | 660 | 600 | 600 | 600 | 594 |
Shares Outstanding (Diluted) | 720 | 660 | 600 | 600 | 600 | 594 |
Shares Change | 20.03% | 10.03% | - | - | 1.04% | 31.96% |
EPS (Basic) | -0.06 | -0.02 | 0.02 | 0.08 | 0.15 | 0.14 |
EPS (Diluted) | -0.06 | -0.02 | 0.02 | 0.08 | 0.15 | 0.14 |
EPS Growth | - | - | -80.18% | -44.44% | 6.30% | -2.53% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -128.76 | -17.73 | -55.32 | 3.38 | 114.06 | -12.38 |
Free Cash Flow Per Share | -0.18 | -0.03 | -0.09 | 0.01 | 0.19 | -0.02 |
Dividend Per Share | - | - | - | - | - | 0.014 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 14.82% | 16.23% | 25.79% | 30.28% | 42.73% | 43.92% |
Operating Margin | -26.96% | -11.39% | 11.13% | 19.87% | 32.30% | 31.51% |
Profit Margin | -21.07% | -9.34% | 4.52% | 14.18% | 21.98% | 22.67% |
Free Cash Flow Margin | -64.72% | -12.21% | -25.84% | 0.98% | 28.54% | -3.43% |
EBITDA | -41.15 | -5.12 | 32.88 | 74.36 | 134.21 | 115.8 |
EBITDA Margin | -20.68% | -3.53% | 15.36% | 21.61% | 33.58% | 32.10% |
D&A For EBITDA | 12.5 | 11.42 | 9.05 | 6 | 5.11 | 2.16 |
EBIT | -53.65 | -16.54 | 23.83 | 68.37 | 129.1 | 113.64 |
EBIT Margin | -26.96% | -11.39% | 11.13% | 19.87% | 32.30% | 31.51% |
Effective Tax Rate | - | - | 34.75% | 28.56% | 29.35% | 28.41% |
Advertising Expenses | - | 26.17 | - | 15.91 | 15.91 | 13.07 |